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1. Introduction 
Stress-related changes in visceral perception resulting in enhanced sensitivity to 
physiological and/or experimental visceral stimuli along with hypervigilance are 
considered to play a critical role in the pathophysiology of irritable bowel syndrome (IBS) 
(Elsenbruch et al., 2010; Mayer et al., 2008; Mulak & Bonaz, 2004; Posserud et al., 2004). 
Visceral hypersensitivity present in about two-thirds of IBS patients has been considered a 
biological marker in IBS (Bouin et al., 2002; Mertz et al., 1995). Numerous studies have also 
reported coexisting somatic hypersensitivity in IBS, although results are not unanimous 
(Chang et al., 2000; Iovino et al., 2006), most likely due to methodological issues, 
heterogeneity of IBS patient subgroups, or concomitant disorders (e.g., fibromyalgia) 
(Moshiree et al., 2007; Verne et al., 2001). The widespread character of hypersensitivity has 
been related to both peripheral and central mechanisms (Azpiroz et al., 2007; Piché et al., 
2010). Alterations in the central nervous system (CNS) circuitries responsive to visceral 
input have been recently delineated in IBS patients compared with healthy subjects using 
functional brain imaging techniques (Song et al., 2006; Wilder-Smith et al., 2004). Evidence 
of spinal nociceptive facilitation in IBS has been also provided (Coffin et al., 2004). 
Over the past 15 years, various animal models have been developed to gain a deeper insight 
into the central and peripheral mechanisms of visceral hypersensitivity (Holschneider et al., 
2011; Mayer et al., 2008). However, only recently has the role of alterations in descending 
pain modulatory pathways in the pathophysiology of IBS and experimental models of IBS 
been recognized (Berman et al., 2008; Larauche et al., 2011a; Larauche et al., 2011b; Wilder-
Smith et al., 2004). In this chapter, we will review the recent developments on stress-related 
modulation of visceral sensitivity to colorectal distension (CRD), with a special focus on 
alterations in stress-induced visceral analgesia and pain inhibitory mechanisms. 
2. Mechanisms of widespread hypersensitivity in IBS 
Several underlying mechanisms have been implicated independently or synergistically to 
account for the widespread hypersensitivity in IBS. Changes in excitability of central 
neurons and processes called ‘central sensitization’ contribute to the maintenance of 
secondary hyperalgesia (i.e. increased sensitivity to stimuli from uninjured tissues adjacent 
to or at some distance from the site of injury). Spinal sensitization could explain both 
visceral hypersensitivity and secondary hyperalgesia found in lumbosacral dermatomes, 
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consistent with the viscerosomatic convergence on spinal neurons (Verne et al., 2001). In 
support of this contention, the local rectal application of lidocaine reversed visceral and 
cutaneous hyperalgesia in the lower limbs of IBS patients (Verne et al., 2003). Likewise, in 
animal models, 25% of rats receiving intracolonic administration of trinitrobenzene sulfonic 
acid to induce colitis displayed long-lasting hypersensitivity to both rectal distension and 
somatic stimuli such as heat stimulus applied to the foot or tail (Zhou et al., 2008). The 
hypersensitivity was the most pronounced in lumbosacral dermatomes, and intracolonic 
lidocaine administration normalized both rectal and somatic hypersensitivity (Zhou et al., 
2008). In addition, an altered descending modulation (discussed in the next paragraph) may 
also play an important role. Pain facilitation processes associated with psychological factors 
are important components contributing to the hypersensitivity as well, along with pain 
inhibition deficits observed in IBS. In fact, heightened levels of anxiety and depression in IBS 
patients correlate with lower sensory thresholds to gut distension (Bouin et al., 2002; 
Posserud et al., 2004).  
3. Descending pain modulatory system 
The periaqueductal gray matter (PAG) and the nucleus raphe magnus, as well as nearby 
structures of the rostral ventromedial medulla (RVM) with their projections to the spinal 
dorsal horn, constitute a pain-control system that ‘descends’ from the brain onto the spinal 
cord (Vanegas & Schaible, 2004). Importantly, this endogenous descending pain modulatory 
system consists not only of inhibitory, but also facilitatory pathways. Persistent nociception 
simultaneously triggers descending facilitation and inhibition. For instance, in models of 
inflammation following the subcutaneous injection of irritants, descending pain inhibition 
predominates over facilitation in response to input from the inflamed tissue, therefore 
attenuating primary hyperalgesia. In the case of secondary hyperalgesia, descending 
facilitation predominates over inhibition in pain circuits with input from adjacent tissues 
(Vanegas & Schaible, 2004). The importance of facilitation of the spinal nociceptive 
processing has been recently recognized as a potential mechanism contributing to the 
pathophysiology of chronic pain conditions, including numerous functional disorders, such 
as IBS (Coffin et al., 2004). In these disorders characterized by persistent pain or discomfort 
without clearly defined tissue pathology, normally innocuous stimulation is incorrectly 
interpreted as noxious, which may originate from input to the RVM from sites rostral in the 
brain (e.g., via cortical, amygdalar or hypothalamic efferents), and be affected by a state of 
attention, anxiety, or cognitive perception (Urban & Gebhart, 1999).  
Numerous studies using inflammatory, neurogenic, or neuropathic models of hyperalgesia 
have shown that the RVM plays a key role in central sensitization which underlies the 
pathogenesis of chronic pain disorders. For example, visceral hyperalgesia associated with 
colonic inflammation could be reversed by the intra-RVM administration of an N-methyl-D-
aspartic acid receptor antagonist, suggesting tonic activity at glutamatergic synapses in the 
RVM (Coutinho et al., 1998). Other neuropeptide modulators present in the rodent RVM 
such as neurotensin or cholecystokinin have also been identified to be tonically active 
following peripheral tissue insult or inflammation (Friedrich & Gebhart, 2003; Gui et al., 
2004; Gebhart, 2004). A noteworthy aspect - in the RVM there are different 
electrophysiologically defined cells, termed ON cells, which are thought to facilitate 
nociception, and OFF cells that inhibit nociception processing (Mason, 2005). Descending 
inhibitory influences from the RVM are confined to the dorsolateral funiculi whereas 
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facilitatory influences descend the spinal cord in the ventral/ventrolateral cord (Gebhart, 
2004). 
4. Monitoring of visceral pain in rodents 
The assessment of pseudoaffective reflex responses (and to a lesser degree, behavioral 
responses) to controlled isobaric distensions of the distal colon has become the primary 
readout and the standard assay for the measurement of visceral pain in rodents since its 
development in 1988 by Ness and Gebhart (Ness & Gebhart, 1988). When applied to rats, 
CRD produces a range of autonomic and behavioral pseudoaffective reflexes (changes in 
arterial pressure and heart rate, passive avoidance behaviors, and contraction of abdominal 
musculature). Monitoring the contraction of abdominal muscles or visceromotor response 
(VMR) is the most commonly used index of visceral pain response in rats and mice. In 
conscious animals, it can be directly assessed by electromyographic (EMG) signals 
monitored via surgically-implanted recording electrodes into the external or internal 
abdominal muscle, where the electrode device is either externalized through the skin 
(abdomen, neck) (Bradesi et al., 2005; Christianson & Gebhart, 2007; Larsson et al., 2003) or 
connected to radiotelemetric implants into the abdominal cavity (Welting et al., 2005). 
Although the method is of significant value in the field of visceral pain, it has experimental 
shortfalls such as damage to EMG electrodes, loss of signal, and electrical interferences, 
which is of particular concern in chronic experimental settings. Additionally, EMG 
implantation requires surgery that encompasses skin and/or muscle incision depending on 
the technique used (subcutaneous abdominal electrodes or intraperitoneal cannula) and 
chronic implantation of a foreign body. Even though no data are available in the literature in 
relation to the immune impact of chronic EMG electrodes placed into the abdominal wall, 
such intervention could induce a host-tissue response with local micro-inflammation 
(neutrophils, lymphocytes and macrophages) as it has been shown for other types of 
implants in the skin and peritoneum (Klueh & Kreutzer, 2005). A recent report suggests that 
the preconditions of animals (EMG surgery, post-surgical delivery of antibiotic and single 
housing) have a considerable impact on the visceral pain responses to CRD, particularly in 
the context of stress studies (Larauche et al., 2010). Other approaches consist of recording 
manometric changes in the pressure of the balloon inserted into the distal colon (Arvidsson 
et al., 2006) or changes in pressure inside the colonic lumen (Larauche et al., 2009; Larauche 
et al., 2010). These two techniques present the advantage of being minimally invasive as they 
do not require surgery and post-surgical treatments such as antibiotics or analgesics which 
can affect the visceral pain responses and still remain an objective and sensitive measure of 
abdominal contractions. However, they entail the partial restraint of animals in Bollman 
cages, a context to which they need to be habituated and which by itself may bring a 
component of stress. Behavioral approaches such as operant behavioral assays (Ness & 
Gebhart, 1988) have also been used in early studies and capitalized on the learning and fear 
behaviors of animals in response to painful CRD. Furthermore, visual monitoring of the 
abdominal withdrawal reflex (Al-Chaer et al., 2000) has been applied in a few studies, and 
while having the great advantage of being one of the less invasive techniques employed to 
date, it is a very subjective method. Indirect endpoints, such as the marker of neuronal 
activation, Fos protein or extracellular signal-regulated protein kinase expression induced in 
neurons at specific sites in the CNS (Million et al., 2006; Wu et al., 2010), as well as 
functional brain imaging of integrated brain responses to nociceptive stimuli (Wang et al., 
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2008), have also been utilized in some animal studies. These approaches allow for direct 
assessment of neuronal circuitries activated by the visceral pain stimulus and, in the case of 
functional brain imaging, are very similar to the monitoring of CRD responses in IBS 
patients and healthy subjects. Unfortunately, in animals these brain mapping techniques 
require euthanasia and limit the assessment to specific time points. However, as more 
stringent brain imaging approaches are developed in rodents, they will open new venues to 
parallel human studies (Coello et al., 2011; Lee et al., 2010). 
We recently developed an alternative non-invasive method to study visceral sensitivity to 
CRD in conscious mice, using a commercially-available miniaturized pressure catheter to 
record intraluminal colonic pressure (ICP) (Larauche et al., 2010). Briefly, a PE50 catheter 
was taped 2 cm below the pressure sensor of a miniaturized pressure transducer catheter 
(SPR-524 Mikro-Tip catheter; Millar Instruments, Houston, TX). A custom-made balloon (1-
cm width x 2-cm length) (Arvidsson et al., 2006; Christianson & Gebhart, 2007; Kamp et al., 
2003) prepared from a polyethylene plastic bag was tied over the catheter at 1 cm below the 
pressure sensor with silk 4.0. Ligature points were covered with parafilm to prevent any air 
from leaking. To validate the technique, we monitored the VMR to graded phasic CRD by 
simultaneously recording ICP and EMG signals in mice chronically implanted with 
electrodes. We found an excellent correlation between signals from ICP and EMG during 
consecutive ascending phasic distensions between 15 to 60 mmHg when recorded 
simultaneously in the same mice. We also showed that the colonic pain pressure threshold 
to CRD detected by both methods were similar (about 32 mmHg), and consistent with 
values previously reported using EMG and manometry (Arvidsson et al., 2006; Kamp et al., 
2003). As colonic pressure could be altered following abdominal contractions and/or 
contractions of the colonic wall, we assessed the effects of atropine, a muscarinic blocker 
known to inhibit colonic motility (Gourcerol et al., 2009), on the VMR to CRD monitored by 
ICP in naïve mice (Larauche et al., 2010). We found that atropine did not significantly 
modify the phasic CRD-associated ICP changes (Larauche et al., 2010), while inhibiting 
distal colonic motility measured by ICP changes in conscious mice maintained under similar 
recording conditions (Gourcerol et al., 2009). In addition, with the use of the non-invasive 
method, it has been confirmed that buprenorphine, a partial agonist for mu-opioid 
receptors, inhibited visceral sensitivity to graded phasic ascending CRD which is consistent 
with opioid-induced reduction of basal visceral response to CRD in both rats and mice 
(Danzebrink et al., 1995; Larsson et al., 2003). Conversely, an hyperalgesic response to CRD 
can be induced after the intraperitoneal injection of cortagine, a selective corticotropin 
releasing factor receptor subtype 1 (CRF1) agonist, known to act directly on the CRF1 
receptor expressed in the colon (Larauche et al., 2009). A similar, non-invasive method to 
monitor VMR has also been validated in rats (Larauche et al., 2009). Taken together, these 
data have established the reliability of ICP method to assess the modulation of visceral 
sensitivity in conscious rodents (Larauche et al., 2010).  
5. Stress-induced modulation of visceral pain 
By convention, stressors are categorized as exteroceptive (psychological or neurogenic) and 
interoceptive (physical, systemic, visceral or immune) (Herman & Cullinan, 1997; 
Sawchenko et al., 2000). Both have been applied to rodents to investigate the relationship 
between stress and visceral pain modulation (Mayer & Collins, 2002). Dual visceral pain 
responses - hyperalgesia and analgesia have been described in rodents. Stress-induced 
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hyperalgesia has been examined in detail in several recent reviews (Larauche et al., 2011a; 
Larauche et al., 2011b; Mayer, 2008) to which the reader is referred to. By contrast, while 
extensively described in the somatic pain field (Butler & Finn, 2009), to date stress-related 
activation of descending inhibitory pathways under conditions of visceral pain has received 
less attention. Opioids have been implicated in descending inhibition of visceral sensitivity 
to CRD following an acute stress. This is evidenced by the fact that naloxone unmasked 
water avoidance stress (WAS)-induced hyperalgesia to CRD in normal Long-Evans rats and 
exacerbated the pain response to CRD in maternally-separated rats (Coutinho et al., 2002). In 
another study, a non-opioid, neurotensin-dependent visceral analgesic response was 
induced in wild-type mice 6 h after exposure to an acute session of WAS, while neurotensin 
knock-out mice under the same conditions had no analgesia (Gui et al., 2004). In addition, 
male Sprague-Dawley rats exhibited stronger analgesia to WAS than females (Gui et al., 
2004). In another experimental model, a daily short period (15 min) pup separation from the 
mother, occurring from postnatal days 2 to 14, decreased VMR to CRD performed 
immediately after WAS and prevented the development of hyperalgesia 24 h after WAS in 
adult male Long-Evans rats (Schwetz et al., 2005). These data suggest a potential 
upregulation of endogenous pain-modulatory systems by this short maternal separation 
stress (Schwetz et al., 2005). Similar findings have been recently reported in adult Wistar rats 
handled daily for 9 days which develop visceral hypoalgesia in response to CRD that 
becomes significant 7 days after the last handling (Winston et al., 2010). These studies point 
to different types of mild psychological or environmental stressors–induced naloxone 
dependent or independent visceral analgesia as reported for somatic pain (Butler & Finn, 
2009) and indicate a potential sex difference in such a stress-related analgesic response.  
However, importantly, we recently demonstrated that mice that had undergone surgery for 
the placement of EMG electrodes on the abdominal wall and were subsequently singly 
housed to avoid deterioration of the implanted electrodes by cage-mates, developed visceral 
hyperalgesia in response to repeated WAS (1h/day for 10 consecutive days), while mice 
tested for visceral pain using the non-invasive solid-state intraluminal pressure recording 
and kept group housed, developed a strong visceral analgesia under otherwise similar 
conditions of repeated intermittent WAS (Larauche et al., 2010). Collectively, these data 
demonstrate that the state of the tested animal (naïve vs exposed to surgery), its social 
environment (group housing vs single housing, cage enrichment or not), the handling 
performed by the investigator, the methods used to record visceromotor responses (EMG 
requiring surgery and antibiotic post surgery vs manometry not requiring 
surgery/antibiotic), as well as the animal sex can significantly affect the analgesic response 
to exteroceptive stressors. Therefore these preconditions should be carefully detailed in 
describing the experimental setting and taken into consideration in the study design and 
interpretations of the data when investigating the influence of stress on visceral sensitivity 
in experimental animals.  
6. Deficit in pain inhibition in IBS 
The stress-related analgesic response bears very relevant implications to the understanding 
of analgesic mechanisms that can be impaired in visceral pain-associated pathologies such 
as IBS. Deficits in stress-related descending pain inhibition may lay at the origin of both 
somatic and visceral hypersensitivity. Alteration in pain inhibitory modulation was 
observed in IBS patients under conditions of counter-irritation, a clinically well-recognized 
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phenomenon frequently described as "pain inhibits pain” (Le Bars et al., 1979; Wilder-Smith 
et al., 2004). It occurs when response from a painful stimulus is inhibited by another, often 
spatially distant and noxious and relates to mechanisms named diffuse noxious inhibitory 
controls (DNICs) (Le Bars et al., 1979). Counter-irritation modulated via CNS mechanisms 
usually produces robust pain inhibition with residual analgesia persisting during the 
recovery period. Studies using the DNIC model to quantify the central pain sensitization in 
patients with chronic pain syndrome showed that defective DNIC is a risk factor for 
developing these disorders (Edwards et al., 2003; Lautenbacher & Rollman, 1997). 
Interestingly, many IBS patients display a reduced inhibition of evoked somatic or rectal pain 
that normally occur when a noxious stimulus is simultaneously applied to another body area, 
e.g. hot or cold water immersion tests (King et al., 2009; Wilder-Smith et al., 2004). Recent 
studies assessing the correlation between visceral and somatic hypersensitivity in diarrhea-
predominant IBS patients have shown that patients with rectal hypersensitivity display a clear 
concomitant deficit in somatic pain inhibition (Piché et al., 2010). The observed somatic 
hypersensitivity to cutaneous heat stimulation involved different regions of the body but was 
more pronounced in dermatomes in which afferents converge on spinal neurons receiving 
bowel afferents. These data suggest that the coexisting visceral and somatic hypersensitivity 
may depend on both viscerosomatic convergence and generalized spinal hyperexcitability 
(Piché et al., 2010). A deficit in endogenous pain modulation and somatic hypersensitivity 
have also been demonstrated in other recent studies in IBS patients (Heymen et al., 2010; 
Wilder-Smith et al. 2004). Moreover, the spinal transmission of nociceptive signals in IBS 
patients was investigated by analyzing the effects of rectal distensions on EMG recordings of 
the somatic nociceptive flexion (RIII) reflex, an objective index of spinal somatic nociceptive 
processes (Coffin et al., 2004). The results indicated that the RIII reflex was significantly 
facilitated during slow ramp distension, whereas inhibitions induced by rapid distensions 
were significantly reduced in IBS patients compared to healthy controls (Coffin et al., 2004). 
Therefore both reduction in inhibition and active facilitation could contribute to central 
sensitization and secondary hyperalgesia in IBS (Price et al., 2009). 
7. Conclusions 
Based on recent clinical findings demonstrating that IBS patients have a compromised 
engagement of the inhibitory descending pain modulation systems (Berman et al., 2008; 
Coffin et al., 2004; Piché et al., 2010; Song et al., 2006; Wilder-Smith et al., 2004), gaining a 
deeper understanding of mechanisms involved in the expression of stress-induced visceral 
analgesia, or lack thereof, are promising avenues to be explored and may lead to new 
therapeutic targets for IBS. Therefore the use of non-invasive methods of monitoring VMR 
that allows the unraveling of the analgesic influence of stress on visceral pain represents a 
step forward to gain insight into the underlying mechanisms, in particular the neural 
substrates and neurochemistry of stress-related analgesia as established in the somatic pain 
field (Butler & Finn, 2009). 
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